Reed Elsevier Rating Reiterated by Societe Generale (REL)

Share on StockTwits

Reed Elsevier (LON:REL)‘s stock had its “buy” rating reiterated by investment analysts at Societe Generale in a note issued to investors on Monday, StockRatingsNetwork.com reports. They currently have a GBX 1,035 ($17.01) target price on the stock. Societe Generale’s price objective would suggest a potential upside of 16.69% from the stock’s previous close.

Several other analysts have also recently commented on the stock. Analysts at Barclays reiterated an “overweight” rating on shares of Reed Elsevier in a research note to investors on Wednesday, January 29th. They now have a GBX 1,025 ($16.84) price target on the stock. Separately, analysts at Citigroup Inc. raised their price target on shares of Reed Elsevier from GBX 950 ($15.61) to GBX 1,100 ($18.08) in a research note to investors on Monday, January 27th. They now have a “buy” rating on the stock. Finally, analysts at Numis Securities Ltd raised their price target on shares of Reed Elsevier from GBX 994 ($16.34) to GBX 1,031 ($16.94) in a research note to investors on Monday, January 13th. They now have an “add” rating on the stock. Six equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and twelve have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of GBX 840.12 ($13.81).

Shares of Reed Elsevier (LON:REL) traded up 0.51% on Monday, hitting GBX 891.50. The stock had a trading volume of 947,821 shares. Reed Elsevier has a 1-year low of GBX 677.50 and a 1-year high of GBX 938.00. The stock’s 50-day moving average is GBX 896.7 and its 200-day moving average is GBX 855.5. The company’s market cap is £10.466 billion.

Reed Elsevier PLC is a provider of professional information solutions. As of December 31, 2011, the Company was organized in five business segments: Elsevier, providing scientific, technical and medical information solutions; LexisNexis Risk Solutions, providing risk information and analytics to business and government customers; LexisNexis Legal & Professional, providing legal, tax, regulatory and business information solutions to professionals, business and government customers; Reed Exhibitions, organising trade exhibitions and conferences, and Reed Business Information, providing information and marketing solutions to business professionals.

Receive News & Ratings for Reed Elsevier Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reed Elsevier and related companies with Analyst Ratings Network's FREE daily email newsletter.

Latest News

Zacks Reaffirms “Neutral” Rating for Portfolio Recovery Associates
Zacks Reaffirms “Neutral” Rating for Portfolio Recovery Associates
MGIC Investment Corp. Given Neutral Rating at Zacks
MGIC Investment Corp. Given Neutral Rating at Zacks
Avery Dennison Corp’s “Neutral” Rating Reaffirmed at Citigroup Inc.
Avery Dennison Corp’s “Neutral” Rating Reaffirmed at Citigroup Inc.
Analysts’ Upgrades for October, 21st
Analysts’ Upgrades for October, 21st
Retail Opportunity Investments Corp Receives New Coverage from Analysts at Wells Fargo & Co.
Retail Opportunity Investments Corp Receives New Coverage from Analysts at Wells Fargo & Co.
Illumina Price Target Raised to $180.50
Illumina Price Target Raised to $180.50


Leave a Reply

 
Advertisement
Advertisement
© 2006-2014 Mideast Time.